跳至主要内容
临床试验/JPRN-UMIN000024817
JPRN-UMIN000024817已完成4 期

Glucose excursions in patients with type 2 diabetes treated with mitiglinide/voglibose versus glimepiride: A randomized cross-over trial - Glucose excursions with mitiglinide/voglibose versus glimepiride

Kitano Hospital0 个研究点目标入组 20 人开始时间: 2016年11月14日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
20

研究概览

简要总结

The mean glucose levels in the mitiglinide/voglibose and glimepiride groups were almost equal. the mitiglinide/voglibose group showed a significantly lower SD of glucose, MAGE, M-value, CONGA-1 value, and AUC >10 mmol/L than the glimepiride group. Hypoglycemia was not observed with mitiglinide/voglibose, whereas it was observed 0.35 times per day with glimepiride.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • patients with insulin dependent diabetes; known allergies to mitiglinide, voglibose, or glimepiride; hepatic dysfunction; renal dysfunction; use of corticosteroids; existing pregnancy; alcoholism; a history of severe hypoglycemic episodes; a history of diabetic ketoacidosis; diabetic retinopathy with a high risk of hemorrhage

研究者

相似试验